Ralago 1 mg tablete
| Name | Ralago 1 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-418240973 |
| Active Substance | razagilin hemitartarat |
| Composition | svaka tableta sadrži 1 mg razagilina (u obliku razagilin hemitartarata) |
| Pharmaceutical Form | tableta |
| Manufacturer | Krka d.d., Novo mesto, Novo Mesto, Slovenija TAD Pharma Gmbh, Cuxhaven, Njemačka |
| Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
| Marketing Authorisation Date | 30.11.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/19-02/256 |
| Registration Number | 381-12-01/154-20-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N04BD02 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
